Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. IN8bio ( (INAB)) has shared an ...
Artificial intelligence has developed rapidly in recent years, with tech companies investing billions of dollars in data centers to help train and run AI models. The expansion of data centers has ...
In June, Business Insider published an investigation into the data center industry. We wanted to dig into the pace of growth in light of the artificial intelligence boom, as well as the resources the ...
Engineering a Time Series Database Using Open Source: Rebuilding InfluxDB 3 in Apache Arrow and Rust
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
On Tuesday, OpenAI announced a partnership with Oracle to develop 4.5 gigawatts of additional data center capacity for its Stargate AI infrastructure platform in the US. The expansion, which ...
On May 30, 2025, The New York Times published an article titled "Trump Taps Palantir to Compile Data on Americans," detailing a supposed combined effort between the U.S. federal government and the ...
The surge in data company acquisitions continued Monday with Snowflake’s purchase of Crunchy Data. Cloud data platform Snowflake announced its intent to acquire Crunchy Data, a Postgres database ...
Repeated doses of INB-200 demonstrate extended median progression-free survival (mPFS) of 16.1 months, more than double the expected 6.9 months typically observed with the standard-of-care (SOC) Stupp ...
The Trump administration has expanded Palantir’s work with the government, spreading the company’s technology — which could easily merge data on Americans — throughout agencies. Alex Karp, a ...
A trove of breached data, which has now been taken down, includes user logins for platforms including Apple, Google, and Meta. Among the exposed accounts are ones linked to dozens of governments. In ...
(RTTNews) - IN8bio, Inc. (INAB), a clinical-stage biopharmaceutical company, Friday announced promising results from its Phase 1 trials of INB-100, an allogeneic gamma-delta T cell therapy for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback